drugset / Trial / NCT01473888

A Study To Evaluate The Effect of T89(Dantonic®)On P450 Enzymes

NCT01473888 ↗

Phase 1 Completed 24 enrolled Tasly Pharmaceuticals, Inc.
NaSingle-groupOpen-label

Summary

Purpose: This study is to determine the effect of T89(Dantonic®)on P450 enzymes. This study will help determine which types of drugs may interact with T89.

Timeline

Start
2011-01
Primary completion
2011-07
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Subject T89 Traditional medicine (herbal / TCM) 225 mg —